COPD: open trials in Japan

9 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT07363694
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Trial Treatment · Phase 2/3 · Pfizer
Fujieda Municipal General Hospital, Fujieda · Nishifukuoka Hospital, Fukuoka · National Hospital Organization Okinawa Hospital, Ginowan · Tokyo Medical University Hachioji Medical Center, Hachiōji · Hiroshima Prefectural Hospital, Hiroshima · Aso Iizuka Hospital, Iizuka-shi · Kure Kyosai Hospital, Kure · Koujunkai Daido Clinic, Nagoya · NHO Kinki-Chuo Chest Medical Center, Sakai · Yamaguchi University Hospital, Ube
Registry updated 2026-10-22
NCT06878261
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Trial Treatment · Phase 3 · AstraZeneca
Research Site, Akashi-shi · Research Site, Chikushino-shi · Research Site, Chiyoda-ku · Research Site, Fukui-shi · Research Site, Fukuoka · Research Site, Gifu · Research Site, Iruma-Gun · Research Site, Ishinomaki · Research Site, Kasuga-shi · Research Site, Kitakyushu-shi · Research Site, Kiyose-shi · Research Site, Kobe · Research Site, Komatsu-shi · Research Site, Kure-shi · Research Site, Kyoto · Research Site, Matsusaka-shi · Research Site, Meguro-ku · Research Site, Minatoku · Research Site, Miyazaki · Research Site, Mizunami-shi · Research Site, Nagaoka-shi · Research Site, Nagasaki · Research Site, Nagoya · Research Site, Nerima-ku · Research Site, Ohta-ku · Research Site, Okayama · Research Site, Osaka · Research Site, Sapporo · Research Site, Sendai · Research Site, Shinjuku-ku · Research Site, Shiogama · Research Site, Takamatsu · Research Site, Takatsuiki-shi · Research Site, Tanabe-shi · Research Site, Toshima-ku · Research Site, Ube · Research Site, Yokohama
Registry updated 2026-10-09
NCT07759245
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Trial Treatment · Phase 2 · Eli Lilly and Company
Tokyo-Eki Center-building Clinic, Chūōku · Kyushu Central Hospital, Fukuoka · Aso Iizuka Hospital, Iizuka · Osaka Keisatsu Hospital, Osaka · Tohoku Medical and Pharmaceutical University Hospital, Sendai · Yamaguchi University Hospital, Ube
Registry updated 2026-10-08
NCT06959095
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Trial Treatment · Phase 3 · GlaxoSmithKline
GSK Investigational Site, Chiba · GSK Investigational Site, Fukuoka · GSK Investigational Site, Fukushima · GSK Investigational Site, Gifu · GSK Investigational Site, Hokkaido · GSK Investigational Site, Hyōgo · GSK Investigational Site, Ibaraki · GSK Investigational Site, Ishikawa · GSK Investigational Site, Kagawa · GSK Investigational Site, Kanagawa · GSK Investigational Site, Kitakyushu-shi · GSK Investigational Site, Kyoto · GSK Investigational Site, Mie · GSK Investigational Site, Nankoku-shi · GSK Investigational Site, Niigata · GSK Investigational Site, Okayama · GSK Investigational Site, Omuta Shi · GSK Investigational Site, Osaka · GSK Investigational Site, Shizuoka · GSK Investigational Site, Tokyo · GSK Investigational Site, Yamaguchi · GSK Investigational Site, Yokohama
Registry updated 2026-10-05
NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Trial Treatment · Phase 3 · AstraZeneca
Research Site, Chūōku · Research Site, Fujieda-shi · Research Site, Fukuoka · Research Site, Kitakyushu · Research Site, Kobe · Research Site, Kure-shi · Research Site, Kyoto · Research Site, Minoh · Research Site, Mizunami-shi · Research Site, Okayama · Research Site, Osaka · Research Site, Osaki-shi · Research Site, Sendai · Research Site, Shinjuku-ku · Research Site, Takamatsu · Research Site, Yamagata · Research Site, Yanagawa-shi · Research Site, Yokohama
Registry updated 2026-10-02
NCT06332885
Zephyr Valve Japan Post-Marketing Surveillance
Research · Pulmonx Corporation
Tosei General Hospital, Aichi · Gifu Prefectural Medical Center, Gifu · Kanagawa Cardio Chest Center, Kanagawa · Kanazawa University Hospital, Kanazawa · St. Marianna University Hospital, Kawasaki · Matsusaka Civic Hospital, Mie · Nagasaki University Hospital, Nagasaki · Nagoya Medical Center, Nagoya · Okayama Medical Center, Okayama · Kinki Chuo Chest Medical Center, Osaka · Hokkaido University Hospital, Sapporo · Tohoku University Hospital, Sendai · Shiga University Hospital, Shiga · Tokyo National Hospital, Tokyo · Fujita Health University Hospital, Toyoake · Dokkyo University Hospital (Pulmonary Medicine and Clinical Immunology), Utsunomiya · Dokkyo University Hospital, Utsunomiya
Registry updated 2026-09-17
NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Trial Treatment · Phase 3 · GlaxoSmithKline
GSK Investigational Site, Gifu · GSK Investigational Site, Mie · GSK Investigational Site, Tokyo
Registry updated 2026-07-28
NCT07311499
Improvement of Sleep in COPD Patients Through Inhalation Management Education by Nurse.
Trial Treatment · Kumamoto University
Kumamoto University, Kumamoto
Registry updated 2025-12-31
NCT05193136
Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease
Research · National Hospital Organization Minami Kyoto Hospital
National Hospital Organization Minami Kyoto Hospital, Jōyō
Registry updated 2023-03-28

All COPD trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error